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The human genome encodes thousands of non-coding RNAs.  Many of these terminate 28 
early and are then rapidly degraded, but how their transcription is restricted is poorly 29 
understood.  In a screen for protein-coding gene transcriptional termination factors, we 30 
identified ZC3H4.  Its depletion causes upregulation and extension of hundreds of unstable 31 
transcripts, particularly antisense RNAs and those transcribed from so-called super-32 
enhancers.  These loci are occupied by ZC3H4, suggesting that it directly functions in their 33 
transcription.  Consistently, engineered tethering of ZC3H4 to reporter RNA promotes its 34 
degradation by the exosome.  ZC3H4 is predominantly metazoan - interesting when 35 
considering its impact on enhancer RNAs that are less prominent in single-celled organisms.  36 
Finally, ZC3H4 loss causes a substantial reduction in cell proliferation, highlighting its overall 37 
importance.  In summary, we identify ZC3H4 as playing an important role in restricting non-38 




















Most of the human genome can be transcribed by RNA polymerase II (Pol II).  57 
Among these transcripts are thousands of long non-coding RNAs, broadly classified as 58 
greater than ~200 nucleotides in length (Kopp and Mendell, 2018).  They share some 59 
structural features with coding transcripts, but most of them are rapidly degraded by the 60 
exosome (Davidson et al., 2019; Preker et al., 2008; Schlackow et al., 2017).  Their 61 
degradation is coincident with or shortly after transcriptional termination, which often occurs 62 
within a few kilobases (kb).  The mechanisms for terminating non-coding transcription are 63 
poorly understood, especially by comparison with those operating at protein-coding genes. 64 
Termination of protein-coding transcription is coupled to 3’ end processing of pre-65 
mRNA via cleavage at the polyadenylation signal (PAS) (Eaton and West, 2020).  A PAS 66 
consists of an AAUAAA hexamer followed by a U/GU-rich region (Proudfoot, 2011).  After 67 
assembly of a multi-protein processing complex, CPSF73 cleaves the nascent RNA and the 68 
Pol II-associated product is degraded 5’3’ by XRN2 to promote termination (Eaton et al., 69 
2018; Eaton et al., 2020; Fong et al., 2015).  The Pol II elongation complex is modified as it 70 
crosses the PAS, which facilitates its termination by XRN2 (Cortazar et al., 2019; Eaton et 71 
al., 2020).  Depletion of XRN2 or CPSF73 causes read-through downstream of some long 72 
non-coding genes (Eaton et al., 2020).  However, a substantial fraction of non-coding 73 
transcription is less sensitive to their depletion suggesting the use of alternative 74 
mechanisms.   75 
The Integrator complex aids termination of many non-coding transcripts, with the 76 
archetypal example being snRNAs (Baillat et al., 2005; Davidson et al., 2020; O'Reilly et al., 77 
2014).  Integrator is also implicated in the termination of promoter upstream transcripts 78 
(PROMPTs) and enhancer RNAs (eRNAs) (Beckedorff et al., 2020; Lai et al., 2015; Nojima 79 
et al., 2018).  The mechanism is analogous to that at protein-coding genes, driven by 80 
endonucleolytic cleavage by INTS11.  However, INTS11 activity does not precede XRN2 81 
degradation at snRNA genes (Eaton et al., 2018).  Moreover, while CPSF73 is indispensable 82 
for termination at protein-coding genes, there is evidence of redundant pathways at snRNA 83 
loci (Davidson et al., 2020).  Indeed, CPSF and the cap binding complex-associated factor, 84 
ARS2, are both implicated in the termination of promoter-proximal transcription (Iasillo et al., 85 
2017; Nojima et al., 2015).   86 
 A variety of processes attenuate transcription at protein-coding genes (Kamieniarz-87 
Gdula and Proudfoot, 2019).  Frequently, this is via premature cleavage and polyadenylation 88 
(PCPA) that can be controlled by U1 snRNA, CDK12, SCAF4/8 or PCF11 (Dubbury et al., 89 
2018; Gregersen et al., 2019; Kaida et al., 2010; Kamieniarz-Gdula et al., 2019).  PCPA is 90 
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common on many genes since acute depletion of the exosome stabilises its predicted 91 
products in otherwise unmodified cells (Chiu et al., 2018; Davidson et al., 2019).  Integrator 92 
activity also attenuates transcription at hundreds of protein-coding genes.  93 
A less-studied termination pathway at some intragenic non-coding regions is 94 
controlled by WDR82 and its associated factors (Austenaa et al., 2015).  In mammals, 95 
WDR82 forms at least two complexes: one with the SETD1 histone methyl-transferase and 96 
another composed of protein-phosphatase 1 and its nuclear targeting subunit PNUTS (Lee 97 
et al., 2010; van Nuland et al., 2013).  A version of the latter promotes transcriptional 98 
termination in trypanosomes (Kieft et al., 2020) and the budding yeast homologue of 99 
WDR82, Swd2, forms part of the APT (associated with Pta1) termination complex (Nedea et 100 
al., 2003).  In murine cells, depletion of either WDR82, PNUTS or SET1 causes non-coding 101 
transcriptional termination defects (Austenaa et al., 2015).  Notably, PNUTS/PP1 is 102 
implicated in the canonical termination pathway at protein-coding genes where its 103 
dephosphorylation of SPT5 causes deceleration of Pol II beyond the PAS (Cortazar et al., 104 
2019; Eaton et al., 2020). 105 
Here, we performed a proteomic screen for new termination factors by searching for 106 
proteins that bind to Pol II complexes in a manner that depends on PAS recognition by 107 
CPSF30.  This uncovered ZC3H4, a metazoan zinc finger-containing factor without a 108 
characterised function in transcription.  Because of the nature of our screen, we anticipated 109 
a role for ZC3H4 in 3’ end formation; however, its effects on this process are mild and apply 110 
to a small number of genes.  Its main function is to restrict non-coding transcription, 111 
especially of PROMPT and eRNA transcripts, which are extended by hundreds of kb when 112 
ZC3H4 is depleted.  ZC3H4 interacts with WDR82, the depletion of which causes similar 113 
defects.  Tethered function assays show that ZC3H4 recruitment is sufficient to restrict 114 
transcription and cause RNA degradation by the exosome.  In sum, we reveal ZC3H4 as a 115 
hitherto unknown terminator of promoter-proximal transcription with particular relevance at 116 
non-coding loci. 117 
 118 
RESULTS 119 
The effect of CPSF30 depletion on the Pol II-proximal proteome 120 
The first step of PAS recognition involves the binding of CPSF30 to the AAUAAA 121 
signal (Chan et al., 2014; Clerici et al., 2018; Sun et al., 2018).  We reasoned that 122 
elimination of CPSF30 would impede PAS-dependent remodelling of elongation complexes 123 
and cause the retention or exclusion of potentially undiscovered transcriptional termination 124 
1 
 
factors.  We used CRISPR/Cas9 genome editing to tag CPSF30 with a mini auxin-inducible 125 
degron (mAID) (Figure 1A).  The integration was performed in HCT116 cells where we had 126 
previously introduced the plant F-box gene, TIR1, required for the AID system to work 127 
(Eaton et al., 2018; Natsume et al., 2016).  CPSF30-mAID is eliminated by 3 hours of indol-128 
3-acetic acid (auxin/IAA) treatment (Figure 1B).  This results in profound and general 129 
transcriptional read-through downstream of protein-coding genes (Figure 1C and Figure 1- 130 
figure supplement 1A) demonstrating widespread impairment of PAS function. 131 
To identify Pol II interactions sensitive to CPSF30, we further modified CPSF30-132 
mAID cells to homozygously tag the largest subunit of Pol II, Rpb1, with mini(m)-Turbo 133 
(Figure 1D and Figure 1- figure supplement 1B).  mTurbo is an engineered ligase that 134 
biotinylates proximal proteins when cells are exposed to biotin (Branon et al., 2018).  This 135 
occurs within minutes of biotin addition to culture media, which is advantageous for 136 
analysing dynamic proteins such as Pol II.  We chose this approach rather than 137 
immunoprecipitation (IP) because it allows isolation of weak/transient interactions (potentially 138 
disrupted during conventional IP) and may identify relevant proximal proteins that do not 139 
interact with Pol II directly.  Importantly, CPSF30-mAID depletion still induced strong read-140 
through in this cell line (Figure 1 - figure supplement 1C).   141 
CPSF30-mAID:RPB1-mTurbo cells were exposed to biotin before western blotting 142 
with streptavidin horseradish peroxidase (HRP).  This revealed multiple bands with a 143 
prominent one corresponding in size to Rpb1-mTurbo and indicating the biotinylation of its 144 
proximal proteome (Figure 1E).  A small number of endogenously biotinylated factors were 145 
observed in the absence of biotin.  Biotin-exposed samples were subject to tandem mass 146 
tagging (TMT) with mass spectrometry.  We focused on proteins with reduced abundance 147 
after auxin treatment (Supplementary File 1).  The factor most depleted was CPSF30, 148 
confirming that its auxin-dependent depletion is reflected in the data (Figure 1F).  As 149 
expected, Rpb1 was the most abundant factor in all samples consistent with its self-150 
biotinylation seen by western blotting. After CPSF30, the most depleted factors were Fip1, 151 
CPSF100 and WDR33, which are in the CPSF complex.  Otherwise, surprisingly few 152 
proteins showed reduced signal following auxin treatment. This implies that the major effect 153 
of CPSF30 depletion on the Pol II-proximal interactome is to prevent the 154 
recruitment/assembly of the CPSF complex.   155 
 156 
ZC3H4 is a candidate transcription termination factor that is metazoan-enriched 157 
Two poorly characterised factors, ZC3H4 and ZC3H6, were the next most depleted.  158 
They contain CCCH zinc finger motifs flanked by intrinsically disordered regions (Figure 1 – 159 
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figure supplement 2A).  Their potential relationship to canonical 3’ end formation factors is 160 
suggested via known/predicted protein-protein interactions that are collated by the STRING 161 
database (Jensen et al., 2009) (Figure 1 – figure supplement 2B).  ZC3H4 is also co-162 
regulated with mRNA processing factors suggesting a role in RNA biogenesis (Figure 1 – 163 
figure supplement 2C; (Kustatscher et al., 2019)).  Although little is reported on ZC3H4, two 164 
independent studies uncovered it as an interaction partner of WDR82 using Mass 165 
Spectrometry (Lee et al., 2010; van Nuland et al., 2013).  WDR82 plays a key role in 166 
transcriptional termination in yeast, trypanosomes and mice (Austenaa et al., 2015; Kieft et 167 
al., 2020; Nedea et al., 2003).  To verify this interaction, we tagged ZC3H4 with GFP and 168 
performed a “GFP trap” whereby ZC3H4-GFP is captured from whole cell lysates using GFP 169 
nanobody-coupled beads (Figure 1 – figure supplement 2D).  WDR82 robustly co-170 
precipitated with ZC3H4-GFP confirming them as interacting partners.  Although WDR82 is 171 
conserved between human and budding yeast our phylogenetic analysis suggested that 172 
ZC3H4 and ZC3H6 are largely restricted to metazoans and are paralogues (Figure 1 - figure 173 
supplement 3A and B).   174 
 175 
ZC3H4 restricts non-coding transcription events 176 
To assess any function of ZC3H4 and/or ZC3H6 in RNA biogenesis we depleted 177 
either or both from HCT116 cells using RNA interference (RNAi) (Figure 2 figure supplement 178 
1A), then deep sequenced nuclear transcripts.  Comparison of these datasets shows that 179 
ZC3H4 loss has a more noticeable impact than ZC3H6 depletion (Figure 2 – figure 180 
supplement 1B).  Specifically, ZC3H6 depleted samples are more similar to control than 181 
those deriving from ZC3H4 loss and ZC3H4/ZC3H6 co-depletion resembles a knock-down of 182 
just ZC3H4.  This was also evident from closer inspection of the data (Figure 2 – figure 183 
supplement 1C), supporting the phylogenetic prediction of their separate functions.  184 
Accordingly, subsequent analyses focus on ZC3H4. 185 
Due to its links with CPSF30 and WDR82, we anticipated that ZC3H4 might affect 186 
transcriptional termination.  We first checked protein-coding genes and found a small 187 
number with longer read-through beyond the PAS when ZC3H4 is depleted (Figure 2A).  188 
However, broader analysis suggests that this is not widespread and far fewer genes exhibit 189 
increased read-through following ZC3H4 loss compared to when CPSF30 is absent (Figure 190 
2B and Figure 2 – figure supplement 2A-D).  Interestingly, the metagene in Figure 2B 191 
revealed slightly more signal antisense of promoters when ZC3H4 is depleted.  This 192 
indicates an effect on non-coding RNA, which is interesting in light of a previously described 193 
function for WDR82 in restricting intragenic transcription (Austenaa et al., 2015).  These 194 
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PROMPT transcripts are normally rapidly degraded  3’5’ by the exosome (Preker et al., 195 
2008).  Figure 2C shows an example PROMPT, upstream of MYC, which is undetectable in 196 
control siRNA treated cells, but abundant following ZC3H4 depletion.  Loss of ZC3H4 also 197 
leads to the extension of this transcript by more than 100 kilobases.  This is made clearer by 198 
comparing the loss of ZC3H4 to AID-mediated depletion of the catalytic exosome (DIS3) 199 
(Davidson et al., 2019).  DIS3 depletion stabilises the usual extent of PROMPT RNA, which 200 
is much shorter than when ZC3H4 is absent.  Importantly, meta-analysis reveals similar 201 
effects at many other PROMPTs (Figure 2D).  These data strongly suggest that PROMPT 202 
transcripts are stabilised and extended in the absence of ZC3H4, presumably because its 203 
normal function restricts their transcription.   204 
The finding that PROMPTs are affected by ZC3H4 suggested a role in the 205 
transcription/metabolism of antisense/non-coding RNAs.  We therefore extended our search 206 
for potential ZC3H4 regulated transcription to enhancer regions since they also produce 207 
short RNAs that are degraded by the exosome (Andersson et al., 2014).  eRNAs can be 208 
found in isolation and in clusters called super-enhancers (SEs) (Pott and Lieb, 2015).  SEs 209 
are thought to be important for controlling key developmental genes with strong relevance to 210 
disease (Hnisz et al., 2013).  ZC3H4 depletion has a clear effect over SE regions 211 
exemplified by the MYC SE where upregulation and extension of eRNAs is obvious (Figure 212 
2E).  Acute depletion of DIS3 illustrates the normally restricted range of individual eRNAs 213 
within the cluster.  This effect is general for other SEs as demonstrated by the metaplots in 214 
Figure 2F.  We also checked the effect of CPSF30 depletion on example PROMPT and SE 215 
transcription, which are very modest and consistent with the lack of antisense effect seen by 216 
metagene in Figure 1C (Figure 2 – figure supplement 2E).  Consistently, PROMPTs 217 
susceptible to ZC3H4 were not enriched in PASs compared to those unaffected by it and 218 
harbour a slightly lower density (Figure 2 – figure supplement 2F).  Overall, these data 219 
strongly suggest that ZC3H4 is important for regulating transcription across many PROMPTs 220 
and SEs.   221 
Comparison of ZC3H4 and Integrator effects 222 
 ZC3H4 has some functions in common with the Integrator complex.  This is a 223 
metazoan-specific assembly with regulatory functions at non-coding loci (Lai et al., 2015; 224 
Mendoza-Figueroa et al., 2020; Nojima et al., 2018).  We previously sequenced chromatin-225 
associated RNA derived from HCT116 cells RNAi depleted of the Integrator backbone 226 
component INTS1 (Davidson et al., 2020).  Chromatin-associated RNA is purified via 227 
urea/detergent extraction and is enriched in nascent RNAs (Wuarin and Schibler, 1994).  228 
Metagene analysis of this data at protein-coding genes shows a mild effect of Integrator 229 
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depletion over PROMPT regions (Figure 3A).  It also reveals an accumulation of promoter-230 
proximal RNAs in the coding direction consistent with a recent report on its function as an 231 
attenuator of protein-coding transcription (Lykke-Andersen et al., 2020).  Because of this 232 
function, Integrator depletion can lead to increased expression of a subset of mRNAs (Elrod 233 
et al., 2019; Lykke-Andersen et al., 2020; Tatomer et al., 2019).  HAP1 is an example of a 234 
gene where this is seen (Figure 3B).  Similarly, we saw evidence for increased mRNA 235 
expression on some genes when ZC3H4 was depleted (Figure 3C).  Interestingly these two 236 
genes are selectively effected by Integrator or ZC3H4 respectively and additional examples 237 
of this are shown in Figure 3 – figure supplement 1A.  Bioinformatic analysis revealed 238 
around 1000 genes affected by INTS1 or ZC3H4 depletion with little overlap between the 239 
two conditions (Figure 3D, Supplementary File 4).  Indeed, analysis of recently published 240 
metabolically labelled RNA-seq data from HeLa cells depleted of the catalytic Integrator 241 
subunit or ZC3H4 reveals several hundred upregulated mRNAs - also with minimal overlap 242 
(Austenaa et al., 2021; Lykke-Andersen et al., 2020) (Figure 3 – figure supplement 1B). 243 
When searching for characteristics of these targets in our HCT116 data, we found that 244 
transcripts upregulated following either ZC3H4 or INTS1 loss are normally expressed at 245 
lower levels than unaffected genes (Figure 3E).  This is consistent with the idea that they are 246 
subject to repression by these two factors under these experimental conditions.         247 
The most prominent effects of ZC3H4 were observed at PROMPT and SE regions 248 
where, again, Integrator is implicated (Lai et al., 2015; Nojima et al., 2018).  Where ZC3H4 249 
effects are evident over PROMPT regions, they are generally more substantial than those 250 
seen after Integrator loss, exemplified by the ITPRID2 PROMPT in Figure 3F and via meta-251 
analyses (Figure 3 – figure supplement 1C and D).  At SEs, ZC3H4 depletion generally 252 
results in a greater stabilisation and elongation of eRNA, compared to INTS1 knock-down, 253 
exemplified at the MSRB3 SE (Figure 3G).  Meta-analysis confirms less effect of INTS1 254 
depletion at SEs versus the impact of ZC3H4 (compare Figures 3H and 2F).  We note that 255 
these INTS1 data are on chromatin-associated RNA whereas ZC3H4 images are obtained 256 
from nuclear RNA.  However, as chromatin-associated RNA is more enriched in nascent 257 
transcripts this would be expected to capture more extended non-coding transcription and 258 
not less as is the case here.  Moreover, previously published analyses of Integrator effects 259 
on transcription do not report the long extended non-coding (PROMPT/eRNA) transcripts 260 
that we observe when ZC3H4 is depleted (Beckedorff et al., 2020; Lykke-Andersen et al., 261 
2020). 262 
 263 
Rapid ZC3H4 depletion and re-expression confirms the functions found by RNA-seq 264 
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 ZC3H4 RNAi suggests its widespread involvement in non-coding RNA synthesis and 265 
the regulation of a subset of protein-coding transcripts.  However, RNAi depletion was 266 
performed using a 72 hr protocol and might result in indirect or compensatory effects.  To 267 
assess whether these effects are a more direct consequence of ZC3H4 loss, we engineered 268 
HCT116 cells for its rapid and inducible depletion.  CRISPR/Cas9 was used to tag ZC3H4 269 
with an E.coli derived DHFR degron preceded by 3xHA epitopes (Figure 4A; (Sheridan and 270 
Bentley, 2016)).  In this system, cells are maintained in trimethoprim (TMP) to stabilise the 271 
degron, removal of which causes protein depletion.  Western blotting demonstrates 272 
homozygous tagging of ZC3H4 and that ZC3H4-DHFR is depleted following TMP removal 273 
(Figure 4B).  Depletion was complete after overnight growth without TMP but substantial 274 
protein loss was already observed after 4 hrs allowing us to assess the consequences of 275 
more rapid ZC3H4 depletion. 276 
 TMP-mediated depletion can also be reversed by its re-administration facilitating a 277 
test of whether ZC3H4 effects are reversed by its reappearance.  The western blot in Figure 278 
4C illustrates this by showing that TMP withdrawal depletes ZC3H4-DHFR, which re-279 
appears following 4 hrs TMP addition.  To ask whether ZC3H4 effects are an immediate 280 
consequence of its loss and if they are reversed following its re-appearance, RNA was 281 
isolated from the three conditions shown in the western blot.  This was analysed by qRT-282 
PCR to assess the levels of extended PROMPT (HMGA2, ITPRID2) and SE (MSRB3, 283 
DLGAP1) RNAs (Figure 4D).  All were increased following ZC3H4 loss suggesting that the 284 
effects that we observed by RNAi are not due to compensatory pathways.  Although 4 hr 285 
TMP re-administration does not restore ZC3H4 to full levels, it was sufficient to reverse the 286 
effects of its depletion at all tested amplicons.  The timescale over which the effect can be 287 
reversed suggests that transcripts induced by ZC3H4 loss remain relatively unstable.  Rapid 288 
ZC3H4 depletion also confirmed the prediction, from our RNA-seq, that the extended 289 
PROMPT transcripts result from the aberrant transcription of these loci (Figure 4 – figure 290 
supplement 1A and B). 291 
 Another key observation from our nuclear RNA-seq was the potential for ZC3H4 to 292 
restrict the levels of a subset of protein-coding transcripts.  The long-term nature of RNAi 293 
and its detection via nuclear RNA-seq means that it could be an indirect or post-294 
transcriptional effect, respectively.  To test whether mRNA upregulation is an immediate and 295 
transcriptional response to ZC3H4 loss, we isolated chromatin-associated RNA from ZC3H4-296 
DHFR cells grown with or without TMP for 4 hrs.  To additionally confirm their specificity to 297 
ZC3H4 (vs Integrator), we also depleted the catalytic Integrator subunit utilising our 298 
previously engineered cell line in which INTS11 is tagged with a small molecule assisted 299 
shut-off module (Chung et al., 2015; Davidson et al., 2020). qRT-PCR was used to detect 300 
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three transcripts (NWD1, ENO3 and PJVK) that were upregulated by ZC3H4 loss but not 301 
Integrator depletion.  Spliced versions of all three were increased after 4 hrs of ZC3H4 302 
depletion, but unaffected by loss of the catalytic Integrator subunit INTS11 (Figure 4E).  The 303 
effectiveness of INTS11 depletion is illustrated by the substantial increase in U1 snRNA 304 
read-through RNA in its absence.  This demonstrates that some mRNAs are immediately 305 
and selectively upregulated following ZC3H4 loss.     306 
We next asked whether the ZC3H4 interactor, WDR82, impacts the levels of 307 
PROMPT and SE transcripts.  Accordingly, ZC3H4-DHFR cells were treated with control or 308 
WDR82-specific siRNAs (Figure 4F).  We also co-depleted ZC3H4 and WDR82 by removing 309 
TMP from cells first transfected with WDR82 siRNAs.  WDR82 depletion enhanced the level 310 
of all tested transcripts suggesting that it functionally overlaps with ZC3H4 (Figure 4G).  311 
There was no synergistic effect of their co-depletion implying that WDR82 and ZC3H4 do not 312 
act redundantly at the tested loci.  WDR82 is found in complexes containing protein 313 
phosphatase 1 (PP1) and the SETD1A/B methyl transferases (Lee et al., 2010; van Nuland 314 
et al., 2013).  We found that the former but not the latter is implicated in the stability of the 315 
non-coding transcripts selected for this experiment (Figure 4 – figure supplement 1C-E).         316 
ZC3H4 occupies a broad region at a subset of promoters 317 
 We have demonstrated that depletion of ZC3H4 causes widespread defects in non-318 
coding transcription and supresses a subset of protein-coding RNAs.  As these effects are 319 
seen following rapid ZC3H4 depletion, we hypothesised that they may be directly mediated 320 
by its recruitment to relevant loci.  Consistently, its capture in our mTurbo experiment 321 
supports its proximity to chromatin and the presence of CCCH zinc finger domains predict 322 
nucleic acid binding capability.  Therefore, its genomic occupancy was globally investigated 323 
by performing ZC3H4 chromatin immunoprecipitation and sequencing (ChIP-seq) alongside 324 
that of Pol II.    325 
ZC3H4 occupies genes with binding broadly resembling that of Pol II and showing 326 
the greatest enrichment over promoter regions (Figure 5A).  However, many genes that are 327 
occupied by Pol II do not recruit ZC3H4 (Figure 5B).  This might result from low affinity of the 328 
ZC3H4 antibody or that its recruitment to chromatin is bridged since ZC3H4 also directly 329 
crosslinks to RNA in cells (Figure 5 – figure supplement 1A).  However, its differential gene 330 
occupancy is consistent with the selective effects of its depletion.  Interestingly, ZC3H4 331 
occupies a broader promoter region than Pol II suggesting that its function is not restricted to 332 
the precise transcriptional start site.  The width of this peak often corresponds to the normal 333 
extent of PROMPT and eRNA transcription, which is elongated in its absence.  RPL13 is 334 
shown as an example of recruitment of ZC3H4 upstream of the promoter, where its loss 335 
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causes stabilisation and extension of the antisense transcript (Figure 5C).  ZC3H4 is also 336 
strongly recruited to SEs consistent with the RNA effects observed on them following its loss 337 
(Figure 5D).  This is exemplified by the MSRB3 region and generalised by metaplots in 338 
figure 5E.  Although our analyses of eRNA and PROMPTs were guided by our RNA-seq 339 
findings, an unbiased search for peaks of ZC3H4 and Pol II signal confirmed proportionally 340 
greater ZC3H4 occupancy at distal intergenic regions (encompassing SEs) (Figure 5F). 341 
Overall, the HCT116 ChIP-seq demonstrates direct recruitment of ZC3H4 to potential 342 
targets.  One mentioned caveat is the low ChIP efficiency of the ZC3H4 antibody; however, 343 
a ZC3H4 ChIP-seq experiment was recently made available by the ENCODE consortium 344 
(Partridge et al., 2020).  This used a flag-tagged construct and was performed in HEPG2 345 
cells allowing a comparison of our data to that obtained with a high-affinity antibody and in 346 
different cells.  Consistent with our findings, flag-ZC3H4 occupies a subset of Pol II-bound 347 
regions and shows broader distribution than Pol II around promoters (Figure 5G).  Although 348 
HEPG2 cells express fewer SEs than HCT116 cells, the transcribed DLGAP1 example 349 
confirms its occupancy of these regions in both cell types (Figure 5 – figure supplement 1B).  350 
In contrast, the MYC SE is only expressed in HCT116 cells and is not occupied by ZC3H4 in 351 
HEPG2 cells.  In further agreement with our data, bioinformatics assignment of flag-ZC3H4 352 
binding sites yielded “promoter and enhancer-like” as the most enriched terms (Partridge et 353 
al., 2020). 354 
 355 
Engineered recruitment of ZC3H4 suppresses transcription 356 
 The consequences of ZC3H4 recruitment to targets are predicted to be their early 357 
termination and subsequent degradation by the exosome, based on the known fate of 358 
PROMPTs and eRNAs.  To test whether ZC3H4 recruitment can promote these effects, we 359 
established a tethered function assay.  ZC3H4 was tagged with bacteriophage MS2 coat 360 
protein to engineer its recruitment to a reporter containing MS2 hairpin binding sites (MS2hp-361 
IRES-GFP; Figure 6A).  Importantly, RNA from this reporter is unaffected by endogenous 362 
ZC3H4 (Figure 6 – figure supplement 1A).  HCT116 cells were transfected with either of 363 
these three constructs together with MS2hp-IRES-GFP and reporter expression assayed by 364 
qRT-PCR.  Compared to the two controls, tethered ZC3H4-MS2 significantly reduced 365 
reporter RNA expression (Figure 6B).  ZC3H4-MS2 expression does not affect the same 366 
reporter lacking MS2 hairpins (Figure 6 – figure supplement 1B).  This directly demonstrates 367 
that ZC3H4 recruitment is sufficient to negatively regulate RNA expression, mirroring the 368 
upregulation of its endogenous targets seen when it is depleted. 369 
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PROMPTs and eRNAs are degraded on chromatin and we wanted to test whether 370 
ZC3H4-MS2 exerted its effect on these nascent RNAs.  The reporter experiments above are 371 
on total RNA so whether ZC3H4-MS2 exerted its effect at the gene (plasmid) or following its 372 
release was uncertain.  Therefore, we purified chromatin-associated RNA using a salt and 373 
urea-based extraction (Wuarin and Schibler, 1994).  As mentioned previously, this 374 
fractionation enriches nascent endogenous RNAs.  However, nascent RNAs associated with 375 
transfected plasmids also co-purify within this fraction (Dye et al., 2006).  Accordingly, cells 376 
were transfected with MS2hp-IRES-GFP and either ZC3H4-MS2 or MS2-GFP.  We included 377 
an additional primer set to detect RNA uncleaved at the bovine growth hormone (BGH) 378 
poly(A) site.  Because poly(A) site cleavage is co-transcriptional, this primer set should 379 
robustly detect Pol II-associated transcripts.  This amplicon and that upstream of the MS2 380 
hairpins were reduced in this chromatin fraction, strongly suggesting that tethered ZC3H4 381 
acts on nascent RNA (Figure 6C). 382 
 The exosome targets released PROMPT and eRNA transcripts, which could be 383 
promoted by ZC3H4. The results we present for endogenous loci are consistent with this 384 
since PROMPTs and eRNAs are upregulated and elongated when ZC3H4 is depleted.  To 385 
test whether recruited ZC3H4 leads to exosome decay, we transfected MS2hp-IRES-GFP, 386 
together with either MS2-GFP or ZC3H4-MS2, into DIS3-AID cells that were then treated or 387 
not with auxin to eliminate the catalytic exosome.  RNA upstream and downstream of the 388 
MS2 hairpins was detected by qRT-PCR and their ratio plotted (Figure 6D).  Enhanced 389 
levels of upstream versus downstream amplicon were associated with transfection of 390 
ZC3H4-MS2 and is more prominent after depletion of DIS3.  This is consistent with the 391 
hypothesis that recruited ZC3H4 promotes the release of RNA that is a DIS3 substrate 392 
(Figure 6E).  Results presented above show that ZC3H4 functions in transcriptional 393 
regulation.  ZC3H4 may also regulate the stability of its targets; however, to our knowledge, 394 
it has not been found to prominently co-purify with the exosome.   395 
 Finally, we were interested to determine the overall relevance of ZC3H4 to cell 396 
health/growth.  This is made simpler by the ZC3H4-DHFR cell line, which allows permanent 397 
depletion of ZC3H4 by culturing cells without TMP.  Accordingly, we performed colony 398 
formation assays on these cells grown in the presence or absence of TMP (Figure 6F).  Loss 399 
of ZC3H4 was associated with smaller colonies, which demonstrates the importance of 400 





 We have discovered that ZC3H4 controls unproductive transcription, especially at 404 
non-coding loci.  This conclusion is based on its recruitment to loci that give rise to 405 
transcripts that are stabilised and elongated when it is depleted.  Moreover, tethering ZC3H4 406 
to a heterologous reporter RNA is sufficient to promote degradation of the transcript by the 407 
exosome.  We propose that ZC3H4 recruitment drives some of the early transcriptional 408 
termination that is characteristic of many non-coding RNAs, particularly PROMPT and eRNA 409 
transcripts.  The function of ZC3H4 in restraining their transcription may at least partly 410 
explain why PROMPT and eRNA transcripts accumulate as short species when the 411 
exosome is depleted. 412 
 Our discovery of ZC3H4 adds to an increasing number of termination pathways. Most 413 
of these are more relevant during the initial stages of transcription, rather than the more 414 
intensively studied process that occurs at the end of protein-coding genes.  This is evident 415 
from comparing the general requirement for CPSF30 at the 3’ end of protein-coding genes 416 
with the more selective impact of ZC3H4 that is focused more promoter-proximally.  The 417 
effects of ZC3H4 depletion are reminiscent of recent findings on the Integrator complex, 418 
which also controls the early termination of transcription (Elrod et al., 2019; Lykke-Andersen 419 
et al., 2020; Tatomer et al., 2019).  Our initial comparison of transcripts sensitive to either 420 
Integrator or ZC3H4 suggests that they can act on separate RNA targets.  An exciting 421 
possibility is that multiple early termination pathways may contribute to conditional gene 422 
regulation.  It will be important to establish whether ZC3H4 and/or Integrator are naturally 423 
utilised to regulate transcription in this manner.  Their predominance in metazoans may 424 
enable complex gene regulation, for example across cell types or during development.  425 
 ZC3H4 has been proposed as an equivalent to Drosophila Suppressor of Sable 426 
(Su(s)), which negatively regulates transcription via promoter-proximal termination (Brewer-427 
Jensen et al., 2016; Kuan et al., 2004).  ZC3H4 and Su(s) share little sequence homology, 428 
but they have similar structural makeup with zinc fingers flanked by largely disordered 429 
regions.  Su(s) depletion stabilises selected RNAs and causes their aberrant elongation and 430 
stability, mirroring what we see globally following ZC3H4 depletion.  There is no known 431 
catalytic activity for ZC3H4 or Su(s), but they are related to CPSF30 which shows 432 
endonuclease activity in Drosophila and Arabidopsis (Addepalli and Hunt, 2007; Bai and 433 
Tolias, 1996).  It remains to be seen whether ZC3H4 possesses any catalytic activity or 434 
mediates its effects through interaction partners.  Interestingly, IP and mass spectrometry 435 
indicates that WDR82 may be the only interacting partner of Su(s) (Brewer-Jensen et al., 436 
2016).  WDR82 has been shown to bind to Pol II phosphorylated on Serine 5 of its C-437 
terminal domain, which may provide a means to recruit ZC3H4 to promoter-proximal regions 438 
(Lee and Skalnik, 2008). 439 
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The recruitment of ZC3H4 to promoters is consistent with our observation that 440 
promoter-proximal transcription is most affected by its absence.  Since depletion of ZC3H4 441 
causes extended transcription of its targets, it is reasonable to suppose that it normally 442 
restricts their transcription in some fashion.  This might be by controlling the escape of 443 
promoter-proximally paused polymerases or by acting closer to the 3’ end of its target 444 
transcripts.  The fact that ZC3H4 acts somewhat selectively (e.g. not all PROMPTs and 445 
mRNAs are its targets) suggests that elements of specificity are required to explain its 446 
mechanism.  Most obviously, this could be sequences within DNA or RNA, to which ZC3H4 447 
(and Su(s)) binds via ChIP and XRNAX, respectively (see Figure 5 and Figure 5 – figure 448 
supplement 1A).  While our paper was under revision, another report identified ZC3H4 as 449 
affecting the transcription of intragenic loci in mammalian cells (Austenaa et al., 2021). In 450 
agreement with our findings, non-coding transcripts were affected by ZC3H4 depletion. It 451 
was proposed to terminate some non-coding transcripts as a result of spurious/weak 452 
splicing. Similarly, Su(s) regulation of transcription was linked to the presence of a cryptic 5’ 453 
splice site (Kuan et al., 2004).  This suggests involvement with U1 snRNA, which recognises 454 
this sequence.  While U1 snRNA inhibition does cause some stabilisation of PROMPTs, it 455 
does not generally result in their longer extension and so other cis-acting sequences and 456 
processes may additionally contribute (Oh et al., 2017).  Our evidence that ZC3H4 binds 457 
RNA in cells suggests that it may directly interact with some of its target transcripts and it will 458 
be important to delineate any sequence determinants. 459 
Beyond transcriptional regulation, ZC3H4 occupancy of SEs is interesting.  Other 460 
notable SE-associated factors (e.g. BRD4 and MED1) are much more generally implicated in 461 
Pol II transcription than ZC3H4 (Sabari et al., 2018).  Moreover, they are transcriptional 462 
activators whereas ZC3H4 appears to suppress transcription (or, at least, its RNA output).  463 
Many SE-bound factors are found to have phase separation properties explaining why large 464 
clusters of factors accumulate at these regions (Cho et al., 2018).  While we do not know 465 
whether ZC3H4 can phase separate, it contains large regions of intrinsic disorder, which can 466 
promote this property (Figure 1 – figure supplement 2A).  In general, ZC3H4 may offer a new 467 
way to study enhancer clusters, particularly the importance of restricting transcription across 468 
these regions. 469 
In conclusion, we have uncovered ZC3H4 as a factor with a function in restricting 470 
transcription.  Its most notable effects are at non-coding loci where transcriptional 471 
termination mechanisms are less understood than at protein-coding genes.  Further 472 
dissection of ZC3H4 and its targeting should reveal additional important insights into how 473 
this unstable portion of the transcriptome is controlled.  The non-overlapping effects of 474 
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Integrator and ZC3H4 at protein-coding genes indicate the possibility that multiple factors 475 
may control gene output via premature transcriptional termination. 476 
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Cell culture 490 
HCT116 parental cells and engineered cell lines were tested negative for 491 
mycoplasma and cultured in Dulbecco modified eagle medium, supplemented with 10% 492 
foetal calf serum and penicillin streptomycin (Gibco). For RNAi, 6 or 24-well dishes were 493 
transfected with siRNA using Lipofectamine RNAiMax (Life Technologies) following the 494 
manufacturers’ guidelines. The transfection was repeated 24 hours later and, 48 hours after 495 
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the first transfection, RNA was isolated. For MS2 assays, cells were seeded in 24-well 496 
dishes overnight, then transfected with 50ng MS2hp-IRES-GFP and 100ng of MS2-GFP, 497 
ZC3H4-MS2 or ZC3H4-GFP using JetPRIME® (PolyPlus) for 24 hours.  To deplete DIS3-498 
AID or PNUTS-AID, auxin was used at a final concentration of 500uM.  To deplete ZC3H4-499 
DHFR, cells were washed twice in PBS and grown in media with or without TMP (30uM). 500 
Cell line generation and cloning 501 
CPSF30-mAID and CPSF30-mAID:RPB1-mTurbo cells were generated using 502 
CRISPR/Cas9-mediated homology-directed repair (HDR).  CPSF30 and RPB1 homology 503 
arms and gRNA sequences are detailed in Supplementary File 7.  The mTurbo insert derives 504 
from 3xHA-mTurbo-NLS_pCDNA3 (#107172, Addgene). For ZC3H4 degron cells, 3xHA-505 
DHFR was amplified from existing CPSF73-HA-DHFR constructs (published in (Eaton et al., 506 
2018)) using non-homologous end-joining (NHEJ) as described in (Manna et al., 2019).  507 
PNUTS-AID cells were constructed using the protocol described in (Davidson et al., 2019).  508 
In general, 6cm dishes of cells were transfected with 1ug of guide RNA expressing px300 509 
plasmid (#42230, Addgene) and 1ug of each HDR template/NHEJ PCR product.  Three days 510 
later cells were seeded, as appropriate, into hygromycin (30µg/ml, final) neomycin 511 
(800µg/ml, final) or puromycin (1µg/ml, final). ZC3H4 cDNA was purchased from Genscript 512 
in a pcDNA3.1(+)-C-eGFP vector.  The MS2hp-IRES-GFP reporter was made by inserting a 513 
BamH1/EcoRV restriction fragment from pSL-MS2-6x (#27118, Addgene) into 514 
pcDNA3.1(+)IRES GFP (#51406, Addgene) also digested with BamH1/EcoRV.    515 
Turbo sample preparation 516 
 10 cm dishes at ~80% confluency were labelled with 500 µM biotin for 10 mins and 517 
the labelling reaction quenched immediately by washing cells in ice cold PBS. Cells were 518 
lysed in RIPA buffer (150 mM NaCl, 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS, 50 519 
mM Tris-HCl at pH 8, 5 mM EDTA at pH 8) containing protease inhibitors (cOmplete mini 520 
EDTA-free tablets, Roche) for 30 mins on ice, then clarified via centrifugation. 350 uL of 521 
washed Streptavidin Sepharose High Performance slurry (GE Healthcare) was incubated 522 
with biotinylated or control lysates with inversion at room temperature for 1 hour. Samples 523 
were then washed twice with RIPA buffer, twice with Urea buffer (2 M urea, 50 mM Tris HCl 524 
pH 8), twice with 100 mM sodium carbonate and once with (20 mM Tris HCl pH 8, 2 mM 525 
CaCl2). Residual final wash buffer was used to re-suspend the beads, which were then flash 526 
frozen in liquid nitrogen and sent for Tandem Mass Spectrometry at The University of Bristol 527 
Proteomics Facility.  528 
 529 
Identifying mass spectrometry candidates 530 
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 First, contaminant proteins (e.g. keratin) or those that are known to be preferentially 531 
biotinylated in ligase assays (e.g. AHNAK) were excluded. Samples with an average 532 
abundance ratio of < 0.70 were classified as having a decreased interaction with RNA 533 
polymerase II following CPSF30 depletion. Finally, proteins with < 5 peptides were 534 
discarded. Remaining candidates were plotted in Figure 1F.   535 
qRT-PCR 536 
 1 µg of total RNA (DNase treated) was reversed transcribed using random hexamers 537 
according to manufacturer’s instructions (Protoscript II, NEB); cDNA diluted to 50uL. qPCR 538 
was performed using LUNA SYBR (NEB) on a Rotorgene (Qiagen). Fold changes were 539 
calculated using Qiagen’s software based on delta CT values.  Graphs were plotted using 540 
Prism (GraphPad).  Numbers underpinning qPCR-derived bar graphs are provided in source 541 
data file 1. 542 
Antibodies 543 
 CPSF30 (A301-585A-T, Bethyl), RNA Pol II (ab817, Abcam), PNUTS (A300-439A-T, 544 
Bethyl), WDR82 (D2I3B, Cell Signalling), EXOSC10 (sc-374595, Santa Cruz), ZC3H4 545 
(HPA040934, Atlas Antibodies), HA tag (clone 3f10, 11867423001, Roche), GFP (PABG1, 546 
Chromotek), TCF4/TCF7L2 (C48H11, Cell Signalling).  Uncropped western blots are 547 
provided in source data file 2. 548 
GFP Trap 549 
 10 cm dishes were transfected (5ug plasmid, 24 hrs), washed with PBS and lysed for 550 
30 mins on ice in 1 mL lysis buffer (150 mM NaCl, 2.5 mM MgCl2, 20 mM Tris HCl pH 7.5, 1 551 
% Triton X-100, 250 units Benzonase [Sigma]).  Samples were then clarified through 552 
centrifugation (12000xg, 10 mins), split in two and incubated with 25ul of GFP TRAP 553 
magnetic agarose (Chromotek) for 1hr with rotation at 4°C.  Beads were washed 5x with 554 
lysis buffer and samples eluted by boiling in 2xSDS buffer before analysis by western 555 
blotting.  556 
Nuclear RNA-Seq 557 
Nuclei were extracted from 1x 30mm dish of cells per condition using hypotonic lysis 558 
buffer (10 mM Tris pH5.5, 10 mM NaCl, 2.5 mM MgCl2, 0.5% NP40) with a 10% sucrose 559 
cushion and RNA was isolated using Tri-reagent. Following DNase treatment, RNA was 560 
Phenol Chloroform extracted and ethanol precipitated. After assaying quality control using a 561 
Tapestation (Agilent), 1 μg RNA was rRNA-depleted using Ribo-Zero Gold rRNA removal kit 562 
(Illumina) then cleaned and purified using RNAClean XP Beads (Beckman Coulter). Libraries 563 
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were prepared using TruSeq Stranded Total RNA Library Prep Kit (Illumina) and purified 564 
using Ampure XP beads (Beckman Coulter). A final Tapestation D100 screen was used to 565 
determine cDNA fragment size and concentration before pooling and sequencing using 566 
Hiseq2500 (Illumina). 567 
ChIP-qPCR 568 
 Cells were cross-linked for 10 mins at room temperature (1% Formaldehyde) and 569 
quenched for 5 mins (125mM Glycine).  Cells were washed in PBS, pelleted (500xg) and 570 
resuspended in 400ul RIPA buffer (150 mM NaCl, 1% NP40, 0.5% sodium deoxycholate, 571 
0.1% SDS, 50 mM Tris-HCl at pH 8, 5 mM EDTA at pH 8).  Sonication was then performed 572 
in a Bioruptor (30 seconds on/30 seconds off x10 on high setting) and debris pelleted 573 
(13000rpm x 10mins).  Supernatants were then incubated for 2hr at 4oC with 40ul of sheep 574 
anti-mouse dynabeads to which 4ug of anti-Pol II (or, as a control, nothing) was pre-bound.  575 
Beads were washed 6x with RIPA buffer and then bound chromatin was eluted by 30 min 576 
incubation at room temperature with rotation (500ul 0.1 M NaHCO3 + 1% SDS).  Cross-links 577 
were reversed overnight at 65oC with the addition of 20ul 5M NaCl.  Following phenol 578 
chloroform extraction and ethanol precipitation, chromatin was resuspended in 100ul water 579 
of which 1ul was used per qPCR reaction.   580 
ChIP-Seq 581 
ChIP libraries were prepared using SimpleChIP® Plus Enzymatic Chromatin kit 582 
(9005, Cell Signalling) according to manufacturer’s instructions. 5µg of RNA Pol II (abcam, 583 
8WG16) or ZC3H4 (HPA040934, Atlas Antibodies) were used for immunoprecipitation, 584 
Dynabeads α-Mouse / α-Rabbit (Life Technologies) were used for capture.  585 
Chromatin RNA isolation 586 
HCT116 cells were scraped into PBS, pelleted, incubated in hypotonic lysis buffer 587 
(HLB; 10 mM Tris.HCl at pH 7.5, 10 mM NaCl, 2.5 mM MgCl2, 0.5% NP40), underlayered 588 
with 10% sucrose (w/v in HLB) on ice for 5 mins, then spun at 500 xg to isolate nuclei. 589 
Supernatant and sucrose was removed and nuclei re-suspended in 100 μL of NUN1 (20 mM 590 
Tris-HCl at pH 7.9, 75 mM NaCl, 0.5 mM EDTA, 50% glycerol, 0.85 mM DTT), before being 591 
incubated with 1 mL NUN2 (20 mM HEPES at pH 7.6, 1 mM DTT, 7.5 mM MgCl2, 0.2 mM 592 
EDTA. 0.3 M NaCl, 1 M urea, 1% NP40) on ice for 15 mins. Samples were spun at 13, 000 593 
xg to pellet chromatin, this was dissolved in Trizol and RNA extracted.  594 
Colony formation assays 595 
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ZC3H4-DHFR cells were seeded into 100mm dishes and maintained in the presence 596 
or absence of TMP for 10 days, with media replaced every 3 days.  Colonies were fixed in 597 
ice cold methanol for 10 mins and then stained with 0.5% crystal violet (in 25% methanol) for 598 
10 minutes. 599 
XRNAX 600 
We essentially followed the protocol of (Trendel et al., 2019). HCT116 cells were 601 
grown overnight in the presence or absence of doxycycline in 10 cm dishes. 24 hr later, 602 
dishes were washed with PBS, UV cross linked (Stratalinker 1800 150 mJ/cm2), or not, then 603 
re-suspended in 4.5 mL Trizol (Sigma). 300 uL of chloroform was added, samples agitated 604 
on a ThermoMixer (Eppendorf) for 5 mins, span at 12000xg for 15 minutes, then the 605 
interphase carefully aspirated into fresh tubes. The interphase was washed thrice with Tris-606 
SDS (10 mM Tris-HCL pH 7.5, 1 mM EDTA, 0.1 % SDS), before being dissolved in 1 mL 607 
Tris-SDS. 1 uL glycogen, 60 uL of 5M NaCl and 1 mL isopropanol were added and samples 608 
precipitated at -20’C for 10 minutes, then pelleted at 18, 000xg for 15 mins. Precipitated 609 
protein was washed with 70 % ethanol, air dried, re-suspended in 180 uL water and pellets 610 
dissolved on ice. DNA was removed via TurboDNase (ThermoFisher) treatment, before 611 
samples were re-pelleted, re-dissolved in RNase buffer (150 mM NaCl, 20 mM Tris-HCL pH 612 
7.5, 2.5 mM MgCl2) and RNA digested with RNase H (NEB) and 1 uL of RNAse T1 (Roche). 613 
4 x SDS loading buffer was added before gel electrophoresis and western blotting.   614 
Computational analysis 615 
 All sequencing data were uploaded to the Galaxy web platform and processed as 616 
detailed below; usegalaxy.org and usegalaxy.eu servers were used.  617 
Datasets (GEO accessions) 618 
Data newly generated in this paper (GSE163015); Pol II HEPG2 ChIP-seq 619 
(GSE32883); ZC3H4 HEPG2 ChIP-seq (GSE104247); DIS3-AID HCT116 RNA-seq 620 
(GSE120574); INTS1 RNAi Chromatin-associated RNA-seq (GSE150238).  4sU labelled 621 
RNA differential expression in HeLa cells depleted of INTS11 or ZC3H4 (GSE133109, 622 
GSE151919). 623 
RNA-Seq alignment 624 
 FASTA files were trimmed using Trim Galore! and mapped to GRCh38 using HISAT2 625 
using default parameters (Kim et al., 2015). Reads with a MAPQ score of < 20 were 626 
removed from alignment files using SAMtools (Li et al., 2009). Finally, BigWig files were 627 
generated using DeepTools and visualised using IGV (Ramirez et al., 2014). 628 
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ChIP alignment and visualisation 629 
 All samples were mapped against GRCh38 using BWA, default settings. Reads with 630 
a MAPQ score of < 20 were removed along with PCR duplicates from alignment files using 631 
SAMtools. Processed BAM files were converted to BigWig files using DeepTools: all 632 
samples were normalised to RPKM with a bin size of 1. Aligned files were visualised using 633 
IGV.  634 
ChIP peak calling 635 
 For ZC3H4 and INPUT, broad peaks were called separately using MACS2 with a 636 
changed “lower mfold” (2) and default settings. For each experiment, bedtools was used to 637 
establish common peaks from individual reps (Intersect Intervals), creating a bed file of high 638 
confidence peaks.  For ZC3H4, peaks called in the INPUT sample were subtracted via 639 
bedtools. All bed files were annotated and plotted in R using ChipSeeker (Yu et al., 2015). 640 
Gene heatmaps 641 
 For ChIP heatmaps, computematrix (DeepTools) was used to generate score files 642 
from ChIP bigwig files using an hg38 bed file; parameters used for each heat map are 643 
detailed in figure legends. Plots were redrawn in R.  Transcription read-through analysis was 644 
calculated for each condition by comparing the first 1 kb downstream of the TES to a 500 bp 645 
region directly preceding the TES (PAS).  A log2 ratio (depletion/control) was then applied to 646 
identify increased read-through.  647 
Super-enhancer metaplots 648 
 A bed file with the coordinates of super-enhancer locations from dbSUPER in 649 
HCT116 cells was used as a basis (Khan and Zhang, 2016). All regions that had clusters of 650 
MED1, Pol II and H3K27ac ChIP signal were retained as bone fide regions of interest, those 651 
without were discarded. A log2 ratio of experiment vs input was prepared using 652 
BamCompare of DeepTools - for RNAseq metaplots, BAM files were split by strand. A score 653 
file for the regions in the amended SE bed file was generated via the computematrix function 654 
of DeepTools using the log2 BamCompare output file. Results were plotted in R-studio using 655 
ggplot2.  656 
Gene plots and metaplots 657 
 Split strand metagene plots were generated using RPKM normalised sense and 658 
antisense (scaled to -1) bigwig coverage files separately with further graphical processing 659 
performed in R. For identifying ZC3H4 PROMPT regions ncRNA genes were filtered from 660 
hg38 refgene gtf file to give protein-coding genes that were used with feature counts on 661 
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siCont RNAseq (Liao et al., 2014), to gain read count and gene length. Transcripts per 662 
million (TPM) were calculated for each gene and genes with an expression of < 5 were 663 
filtered out to give a list of expressed genes. Next, divergent promoters, or genes with 664 
neighbours within 5kb of their promoter, were excluded to minimise background. Finally, this 665 
gene list was converted to a bed file, then computematrix (DeepTools) used to generate a 666 
score file from log2 siCont Vs condition bigwigs; results were plotted in R.   667 
Differential gene expression 668 
 FeatureCounts was used to count mapped reads over exons and differential 669 
expression was performed using DESeq2 (Liao et al., 2014; Love et al., 2014).  670 
PROMPT poly-A site detection  671 
 For PROMPT analysis, we used a catalogue of 961 PROMPTs generated by de novo 672 
assembly following acute DIS3 depletion (Davidson et al., 2019). Due to the variable length 673 
of each PROMPT, we searched for the two consensus poly-A site motifs (AWTAAA) across 674 
the full transcript sequence using FIMO (online). We then calculated the total occurrence of 675 
poly-A sites across each PROMPT transcript per kb and separated them into two groups; 676 
those that show upregulation (log2FC ≥1) in the absence of ZC3H4 and those with no 677 
change of downregulated expression. Plots were drawn in R. 678 
 679 
ZC3H4 homologue identification  680 
To identify ZC3H4 homolog protein sequences, sequences from UniRef100 (UniProt 681 
Consortium, 2014) were searched using a profile HMM search: ‘hmmsearch’, part of HMMer 682 
V3.2.1 (Eddy, 2011), with PANTHER (Mi et al., 2019) hidden Markov model PTHR13119, 683 
corresponding to zinc finger CCCH-domain containing proteins. Profile HMM search hits 684 
were filtered using a 1e-100 e-value threshold; this search identified 1513 UniRef100 685 
sequences with PTHR13119 domains (representing a total of 1646 UniProtKB sequences). 686 
PTHR13119 domains from human and mouse were aligned using TCoffee Expresso mode 687 
(Armougom et al., 2006), and multiple sequence alignment figure (Figure 1 – figure 688 
supplement 3B) was rendered with ESPscript (Robert and Gouet, 2014). 689 
Phylogenetic tree reconstruction 690 
Identified PTHR13119 domains were aligned using MAFFT v7.4 (Katoh and 691 
Standley, 2013); sites composed of more than 75% of gaps were removed from the multiple 692 
sequence alignment with trimAl (Capella-Gutierrez et al., 2009). The PTHR13119 domain 693 
phylogeny was reconstructed under maximum likelihood with IQ-TREE v1.6.9 (Nguyen et al., 694 
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2015). The best-fitting substitution matrix was determined by ModelFinder (Kalyaanamoorthy 695 
et al., 2017), as implemented in IQ-TREE. Branch support values were based on 1000 696 
ultrafast bootstraps (Minh et al., 2013). Phylogenetic Tree figure was rendered with iToL 697 
(Letunic and Bork, 2019).  Multiple sequence alignment and phylogenetic tree files are 698 
deposited on Zenodo (https://doi.org/10.5281/zenodo.4637127). 699 
Primers, siRNAs and other nucleic acid sequences 700 
Sequences are provided in Supplementary File 7. 701 
 702 
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FIGURE LEGENDS 932 
Figure 1: Proximity labelling of CPSF30-sensitive Pol II interactions by mTurbo  933 
a) Schematic of the strategy used to tag CPSF30 with the mini auxin-inducible degron 934 
(mAID). Guide RNA-expressing Cas9 plasmid and homology-directed repair (HDR) plasmids 935 
are shown and the resulting modification to CPSF30 is represented with each inserted 936 
element labelled.  937 
b) Western blot demonstrating CPSF30 depletion. Parental HCT116-TIR1, or CPSF30-mAID 938 
cells, were treated +/- auxin for 3 hours then blotted.  CPSF30 protein is indicated together 939 
with a non-specific product, marked by an asterisk, used as a proxy for protein loading. 940 
c) Metagene analysis of 1795 protein-coding genes demonstrating increased downstream 941 
transcription, derived from sequencing nuclear RNA, following auxin treatment (3hr) of 942 
CPSF30-mAID cells. TSS = transcription start site, TES = transcription end site (PAS), read-943 
through signal is normalised against gene body.  RPKM is Reads Per Kilobase of transcript, 944 
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per Million mapped reads.  Positive and negative signals represent sense and antisense 945 
reads, respectively. 946 
d) Schematic of our strategy to identify new factors involved in transcription termination. 947 
CPSF30-mAID cells edited to contain Rpb1-mTurbo (blue circle on Pol II).  The addition of 948 
biotin induces mTurbo-mediated biotinylation (orange haze) of factors proximal to Pol II.  949 
CPSF complex is shown as an example of what might be captured by this experiment. 950 
e) Western blot showing streptavidin HRP probing of extracts from CPSF30-mAID: RPB1-951 
mTurbo cells.  Prior treatment with auxin (3hr)/biotin (10 mins) is indicated.  The high 952 
molecular weight species in the + biotin samples corresponds in size to Rpb1-mTurbo (*). 953 
f) Heat map detailing proteins with the largest decrease in Pol II interaction. Data 954 
underpinning heat map are from mass spectrometry analysis of streptavidin sequestered 955 
peptides (+/- CPSF30) performed in triplicate. Labelling was for 10 minutes.  956 
 957 
Figure 2: ZC3H4 depletion stabilises unproductive transcripts.  958 
a) IGV track of the transcription read-through defect at PTPN11 following CPSF30 or ZC3H4 959 
depletion. Blue and red tracks indicate sense/anti-sense transcripts respectively, grey bar 960 
indicates a change in y-axis scale so that comparatively weaker read-through signals can be 961 
visualised next to the gene body (left scale for upstream of TES; right for downstream). Y-962 
axis scale is RPKM. 963 
b) Metagene comparison of transcription upstream, across, and downstream of, protein-964 
coding genes in nuclear RNA from CPSF30-mAID cells treated or not with auxin and from 965 
HCT116 cells transfected with control or ZC3H4 siRNAs.  CPSF30 traces are from the same 966 
samples presented in Figure 1C.  Positive and negative signals represent sense and 967 
antisense reads, respectively. 968 
c) IGV track view of transcription at the MYC PROMPT in RNA-seq samples obtained from 969 
control or ZC3H4 siRNA treated HCT116 cells.  We also show a track from HCT116 cells 970 
acutely depleted of DIS3-AID (DIS3 +IAA) (Davidson et al., 2019) to highlight the normal 971 
extent of this unstable transcript. Y-axis scale is RPKM. 972 
d) Log2 fold change of siZC3H4 vs siControl or DIS3 + vs - auxin for RNA upstream of 6057 973 
non-neighbouring, actively transcribed genes, plotted as heat maps. Line graphs are an XY 974 
depiction of heat map data.  Log2 fold changes are smaller in siZC3H4 samples versus DIS3 975 
depletion because this is an average of all genes in the heat map, a smaller fraction of which 976 
are affected by ZC3H4. 977 
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e) IGV plot of a known SE upstream of MYC (the location is shown by blue bar under trace).  978 
Samples are shown from HCT116 cells treated with control or ZC3H4 siRNAs as well as 979 
DIS3-AID cells treated with auxin (the latter from (Davidson et al., 2019)) to show the normal 980 
extent of unstable eRNAs over this region.  Y-axis scale is RPKM. 981 
f) Log2 fold change of RNA signal for siZC3H4 vs siControl or DIS3 + vs - auxin for 111 SEs. 982 
The bed file detailing super-enhancer coordinates in HCT116 cells was taken from 983 
dbSUPER.org.  984 
 985 
Figure 3: Comparison of ZC3H4 and Integrator effects 986 
a) Metagene analysis of chromatin-associated RNA-seq performed on cells treated with 987 
control or INTS1-specific siRNA.  The plot shows signals upstream, across and downstream 988 
of protein-coding genes.  Y-axis scale is RPKM.  Positive and negative values represent 989 
sense and antisense reads, respectively. 990 
b/c) IGV traces of HAP1 and NWD1 genes derived from chromatin-associated RNA-seq in 991 
control and INTS1 siRNA treated samples and nuclear RNA-seq from control or ZC3H4 992 
siRNA treatment.  NWD1 transcripts are affected by ZC3H4 but not INTS1 whereas the 993 
opposite is true for HAP1 RNAs.  Y-axes scales are RPKM.   994 
d) Venn diagram showing the number of mRNAs upregulated ≥ 2-fold, padj ≤0.05 following 995 
ZC3H4 depletion versus INTS1 loss and the overlap between the two sets. Genes that 996 
showed increased expression due to transcription read-through from an upstream gene were 997 
also discarded by assessing coverage over a 1 kb region preceding the TSS, relative to 998 
untreated cells.  Gene lists are provided in Supplemental File 3. 999 
e) Graphs demonstrating the expression level of mRNA transcripts upregulated (log2FC >1) 1000 
following ZC3H4 or INTS1 depletion by comparison with transcripts unaffected by loss of 1001 
either factor.  Y-axis shows normalised gene counts (i.e. expression level). 1002 
f) Comparison of chromatin-associated RNA-seq in control and INTS1 siRNA treated 1003 
samples with nuclear RNA-seq derived from control or ZC3H4 siRNA treatment.  The 1004 
ITPRID2 PROMPT is displayed and y-axes are RPKM (note the different scales between 1005 
ZC3H4 and INTS1 samples). 1006 
g) Comparison of chromatin-associated RNA-seq in control and INTS1 siRNA treated 1007 
samples with nuclear RNA-seq derived from control or ZC3H4 siRNA treatment.  The 1008 
MSRB3 SE is displayed and y-axes are RPKM (note the different scales between INTS1 and 1009 
ZC3H4 samples). 1010 
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h) Metaplot of RNA-seq profile over super-enhancers following INTS1 depletion (log2 fold 1011 
depletion/control over 111 super-enhancer as line graphs).  The bed file detailing super-1012 
enhancer coordinates in HCT116 cells was taken from dbSUPER.org. 1013 
 1014 
Figure 4: Transcriptional dysregulation following acute ZC3H4 loss.  1015 
a) Schematic detailing how the DHFR degron works. E. Coli dihydrofolate reductase (DHFR) 1016 
is fused to the C-terminus of ZC3H4, which is stabilised by trimethoprim (TMP).  When TMP 1017 
is removed ZC3H4-DHFR is degraded.  1018 
b) Western blot of HCT116 parental and HCT116 ZC3H4-DHFR cells +/- TMP. TMP was 1019 
withdrawn for 4 hours or overnight, EXOCS10 is used as a loading control, αHA recognises 1020 
a HA peptide before the DHFR tag, while αZC3H4 recognises native protein.  1021 
c) Western blot of ZC3H4-DHFR cells grown under the following conditions: +TMP, -TMP 1022 
(4hr), -TMP (4hr) followed by +TMP (4hr).  ZC3H4-DHFR is detected using αHA and 1023 
EXOSC10 is shown as a loading control. 1024 
d) qRT-PCR analysis of PROMPT and SE transcripts in ZC3H4-DHFR cells grown under the 1025 
conditions represented in c) (rescue refers to –TMP then +TMP for re-establishing ZC3H4).  1026 
Graph shows fold change versus +TMP following normalisation to spliced actin. N=3.  Error 1027 
bars are standard error of the mean (SEM). *. ** and *** denote p values of <0.05, 0.01 and 1028 
0.001 respectively.  ITPRID2 5’ and 3’ primers are at approximately -500bp and -7kb relative 1029 
to its TSS.  HMGA2 5’ and 3’ primers are at approximately -1.8kb and -7.1kb relative to its 1030 
TSS. 1031 
e) qRT-PCR analysis of spliced PJVK, ENO3 and NWD1 mRNAs and RNU1-1 read-through 1032 
(RT) in ZC3H4-DHFR cells grown with or without (4hr) TMP and INTS11-SMASh cells grown 1033 
with or without asunaprevir (ASN; 36 hrs).  Graph shows fold change versus control (+TMP 1034 
for ZC3H4-DHFR samples and –ASN for INTS11-SMASh samples), following normalisation 1035 
to spliced actin.  N=3.  Error bars are SEM. * and ** denote p values of <0.05 and 0.01 1036 
respectively.   1037 
f) Western blot of extracts derived from HCT116 cells transfected with control or WDR82-1038 
specific siRNAs.  The blot shows WDR82 and, as a loading control, EXOSC10. 1039 
g) qRT-PCR of PROMPT and SE transcripts in ZC3H4-DHFR cells transfected with control 1040 
or WDR82 siRNAs before withdrawal, or not, of TMP (14hr).  Graph shows fold change by 1041 
comparison with control siRNA transfected ZC3H4-DHFR cells maintained in TMP following 1042 
1 
 
normalisation to spliced actin transcripts. N=3.  Error bars are SEM.  * and ** denote p<0.05 1043 
and 0.01, respectively. 1044 
 1045 
Figure 5: ZC3H4 occupies regions where transcription is affected by its absence. 1046 
a) ZC3H4 ChIP profile over protein-coding genes is similar to Pol II. Heat map 1047 
representation of ZC3H4 and Pol II ChIP-seq occupancy over the gene body +/- 3 kb.  1048 
b) ZC3H4 occupies fewer promoters than Pol II. IGV track view of ZC3H4 and Pol II 1049 
occupancy over KAZALD1 and FABP5 genes, Pol II is present at both genes, while ZC3H4 1050 
is only present at KAZALD1.  Scale is counts per million (CPM).  Shaded blue box shows 1051 
peak of Pol II and ZC3H4 at KAZALD1 and of Pol II over FABP5.  1052 
c) RNA-seq (HCT116 cells treated with control or ZC3H4 siRNA) and ChIP-seq (Pol II, 1053 
ZC3H4 and input) profiles at RPL13.  ZC3H4 occupancy is focused more on the PROMPT 1054 
transcript region (blue box) than the TSS where, in contrast, the Pol II signal is maximal.  1055 
RNA-seq scale is RPKM and ChIP-seq is CPM.   1056 
d) ZC3H4 ChIP occupancy mirrors Pol II at super-enhancers. IGV track view of ZC3H4 and 1057 
Pol II occupancy over the SE at the MSRB3 locus. HCT116 super-enhancer gene track is 1058 
from dbSUPER and depicted as blue bars.  1059 
e) Log2 fold change of ZC3H4 and Pol II vs input at SEs shown as a line graph. Halo 1060 
denotes 95% confidence level. 1061 
f) ChIPseeker analysis of peak distribution of ZC3H4 and Pol II.  Occupancy regions are 1062 
colour-coded and the number of ChIP peaks expressed as a proportion of 100%. 1063 
g) Heat map showing Pol II and ZC3H4 ChIP occupancy in HEPG2 cells obtained via the 1064 
ENCODE consortium.  Occupancy +/- 2 kb of the TSS is shown. 1065 
 1066 
Figure 6: Directed recruitment of ZC3H4 recapitulates its effects on endogenous 1067 
targets 1068 
a) Schematic of the MS2 system. A reporter plasmid (MS2hp-IRES-GFP) expressing a GFP 1069 
transcript with 6 x MS2 hairpins upstream of an IRES and GFP gene.  ZC3H4-MS2 or MS2-1070 
GFP can be specifically tethered to the MS2 hairpins to assess consequent effects on 1071 
transcription/RNA output.  Positions of primer pairs used in qRT-PCR experiments 1072 
elsewhere in the figure are indicated by labelled horizontal lines under reporter. POI is 1073 
protein of interest. 1074 
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b) qRT-PCR analysis of total RNA isolated from MS2hp-IRES-GFP transfected cells co-1075 
transfected with either MS2-GFP, ZC3H4-GFP or ZC3H4-MS2.  The level of reporter RNA is 1076 
plotted (“UP” amplicon) as a percentage of that obtained in the MS2-GFP sample following 1077 
normalisation to spliced actin. N=3.  Error bars are SEM. * denotes p<0.05. 1078 
c) qRT-PCR analysis of chromatin-associated RNA isolated from MS2hp-IRES-GFP 1079 
transfected cells co-transfected with either MS2-GFP or ZC3H4-MS2.  The level of reporter 1080 
RNA upstream of the MS2 hairpins (UP) and transcripts yet to be cleaved at the BGH 1081 
poly(A) site (BGH UC) are plotted as a percentage of that obtained in the MS2-GFP sample 1082 
following normalisation to spliced actin. N=3.  Error bars are SEM.  * denotes p<0.05. 1083 
d) qRT-PCR analysis of total RNA isolated from MS2hp-IRES-GFP transfected DIS3-AID 1084 
cells co-transfected with either MS2-GFP or ZC3H4-MS2 – simultaneously treated or not 1085 
with auxin (14hr in total).  The graph shows the ratio of RNA species recovered upstream 1086 
(UP) versus downstream (DOWN) of the MS2 hairpins. N=4.  Error bars are SEM.  * denotes 1087 
p<0.05. 1088 
e) Schematic detailing an interplay between ZC3H4 and DIS3 that sees transcription stop 1089 
and nascent RNA degraded 1090 
f) Colony formation assay of ZC3H4-DHFR cells grown in the presence or absence of TMP.  1091 
Cells were grown for 10 days before crystal violet staining. 1092 
 1093 
SUPPLEMENTAL FIGURE LEGENDS 1094 
Figure 1 – figure supplement 1 1095 
a) IGV track views of the transcription termination defect at PCBP1, PSMC2, LSM8 and 1096 
CAV2 genes in the presence (CPSF30-IAA) or absence of (CPSF30 +IAA) in CPSF30-mAID 1097 
cells. Signal is RPKM.  1098 
b) Western blot demonstrating bi-allelic modification of RPB1 (Pol II) with mTurbo.  The 1099 
clone employed in Figure 1 is shown against cells parental HCT116 cells unmodified at 1100 
RBP1.  The upshift of Pol II signal shows the bi-allelic modification of RPB1.  EXOSC10 1101 
serves as a loading control. 1102 
c) qRT-PCR of total RNA isolated from CPSF30-mAID: RPB1- mTurbo cells treated or not 1103 
with auxin (3hr).  An amplicon located ~10kb downstream of the HMGA2 PAS was used to 1104 
assay transcriptional read-through presented as a fold change versus minus auxin after 1105 




Figure 1 – figure supplement 2 1108 
a) Schematic of ZC3H4 and ZC3H6 showing the three CCCH zinc finger domains.  A 1109 
predictor of natural disordered region (PONDR) analysis shows that the only ordered region 1110 
coincides with these domains.  Graph generated via PONDR.com, set to VSL2.   1111 
b) STRING analysis of ZC3H4 and ZC3H6 indicate interactors with 3’ end processing 1112 
complex. Image was taken from string.db.org, confidence value was set to medium (0.4).  1113 
The thickness of lines between nodes is indicative of the confidence in interaction. 1114 
c) Proteins that are co-regulated with ZC3H4 according to ProteomeHD using a score cut-off 1115 
set to 0.98.  Table shows GO term analysis of the potentially co-regulated factors. 1116 
d) Co-immunoprecipitation of WDR82 using ZC3H4-GFP as bait.  Blot shows input (5%) and 1117 
immunoprecpitated material probed with antibodies to WDR82 or GFP.  Cells untransfected 1118 
with ZC3H4-GFP act as a negative control. 1119 
 1120 
Figure 1 – figure supplement 3 1121 
a) Maximum-likelihood phylogenetic tree of zinc finger CCCH-domains (1513 sequences; 1122 
795 parsimony informative sites) inferred under the JTT+R8 model. Clades of ZC3H4-like 1123 
and 845 ZC3H6-like domains are delimited by dashed lines. CCCH-domains identified using 1124 
the PANTHER hidden Markov model PTHR13119 against the UniProtKB protein database 1125 
(non redundant version: UniRef100; external node size represents protein cluster size). 1126 
Branch support values ≥90% (based on 1000 ultrafast bootstraps) are indicated by grey 1127 
circles. Red stars show SwissProt reviewed protein sequences; external nodes are color-1128 
coded according to their taxonomic lineage. Scale bar represents the number of estimated 1129 
substitutions per site. Virtually all recovered sequences were from metazoan organisms—1130 
except for a group of fungal sequences from ascomycetes. The resulting phylogenetic tree 1131 
shows the dichotomy between the ZC3H4 and ZC3H6 domains, which are found in the same 1132 
set of organisms.  This indicates that they are paralogues and have likely diverged their 1133 
function following gene duplication. The ancestral gene coding for ZC3H4/6 was likely lost 1134 
from the non-vertebrates and subsequently underwent a duplication event leading to the 1135 
ZC3H4- and ZC3H6-like paralogues in vertebrates.  Primary data are available in 1136 
Supplementary File 2 and deposited at Zenodo  (https://doi.org/10.5281/zenodo.4637127). 1137 
b) Multiple sequence alignment of ZC3H4 and ZC3H6 homologs. PTHR13119 domains from 1138 
human and mouse SwissProt sequences were aligned using structural information (PDB 1139 
1 
 
structure: 2CQE; zinc-finger domain; helices are displayed as coils) using TCoffee (Expresso 1140 
mode). Conserved regions are indicated by blue boxes; identical and similar residues (based 1141 
on physicochemical properties) are marked in red and yellow, respectively. Sequence 1142 
identifiers correspond to UniProt/SwissProt accession numbers and to boundaries of 1143 
identified PTHR13119 domains. Alignment figure was rendered with ESPscript.  1144 
 1145 
Figure 2 – figure supplement 1 1146 
a) qRT-PCR and western blotting evidence of the effectiveness of ZC3H6 and ZC3H4 1147 
depletion respectively.  Graph shows fold reduction of ZC3H6 mRNA in cells treated with 1148 
ZC3H6 siRNAs versus those transfected with control siRNA.  N=3, error bars are SEM.  ** is 1149 
p<0.01.  Western blotting of ZC3H4 in HCT116 cells treated with control siRNAs or ZC3H4-1150 
targeting siRNAs.  The blot was probed with a ZC3H4 antibody revealing strong depletion 1151 
versus the EXOSC10 loading control.  1152 
b) Pearson’s correlation of siControl, siZC3H4, siZC3H6 and siZC3H4+6 of RNAseq BAM 1153 
files performed by DEEPTOOLS.   1154 
c) IGV traces exemplifying two genomic regions with clear RNA accumulation following 1155 
ZC3H4 depletion.  While this is also seen following ZC3H4/ZC3H6 co-depletion, it is not 1156 
evident following the depletion of ZC3H6 alone.  This was generally seen, supporting the 1157 
correlation analysis in b).  y-axis scale is RPKM. 1158 
 1159 
Figure 2 – figure supplement 2 1160 
a) Heatmaps showing the effects of CPSF30-mAID or ZC3H4 depletion on read-through 1161 
beyond protein-coding genes.  Coloured scale bar indicates the magnitude of effect (log2 1162 
scale).  Read-through was scored as a ratio of reads upstream (500bp) and downstream 1163 
(1kb) of the PAS.  The lists associated with this heatmap are provided in Supplementary File 1164 
3.   1165 
b) Graph showing the number of protein-coding genes with read-through enhancements of 1166 
greater than 0.5, 1, 2 or 3 on a log2 fold scale.  This illustrates that the effects of CPSF30-1167 
mAID loss are both wider spread and larger than those associated with depletion of ZC3H4. 1168 
c) Venn diagram showing the number of genes bioinformatically scored as having increased 1169 
read-through (log2 fold of 1 or more) following CPSF30-mAID or ZC3H4 loss and those that 1170 
are common between the two conditions. 1171 
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d) IGV tracks of individual genes (MAGED1 and DLG3) to exemplify the lack of 3’ 1172 
termination defect following ZC3H4 depletion.  As a control for bone fide read-through, the 1173 
same tracks are shown in samples obtained from CPSF30-mAID cells treated or not (3hr) 1174 
with auxin. Grey bar indicates a change in scale (left scale for upstream of PAS; right for 1175 
downstream) so that comparatively weaker read-through signals can be visualised next to 1176 
the gene body. y-axis scale is RPKM. 1177 
e) CPSF30 depletion shows little effect at super-enhancers and PROMPTs. IGV track view 1178 
of the MYC super-enhancer and PROMPT in RNA-seq data obtained from CPSF30-mAID 1179 
cells treated or not (3hr) with auxin.  y-axis scale is RPKM. 1180 
f) Plot showing the density of PAS sequences (AWTAAA) in PROMPTs upregulated or 1181 
unaffected by ZC3H4 loss.  Y-axis plots number of PAS sequences/kb. 1182 
Figure 3 – figure supplement 1 1183 
a)  IGV snapshots showing examples of protein-coding genes selectively upregulated by 1184 
ZC3H4 (PJVK and ENO3) or Integrator (TM7SF2 and GFPT2).  Y-axis represents RPKM. 1185 
b) Venn diagram showing representing the number of protein-coding transcripts (determined 1186 
by DESEQ2) that show increased levels in previously published 4sU labelling experiments 1187 
performed on HeLa cells depleted of INTS11 or ZC3H4 (Austenaa et al., 2021; Lykke-1188 
Andersen et al., 2020).  Gene lists are provided in Supplementary File 5.  Notably, manual 1189 
curation of this list revealed the presence of false positive hits, especially in the INTS11 data, 1190 
due to DESEQ2 scoring interference of transcription from neighbouring genes as 1191 
upregulation.   1192 
c) Venn diagram showing the number of PROMPTs showing upregulation (log2 fold of 1 or 1193 
more) following ZC3H4 or INTS1 loss from HCT116 cells and those that are common 1194 
between the two conditions. 1195 
d) Graph showing the number of PROMPTs enhanced by greater than 0.5, 1, 2 or 3 on a 1196 
log2 fold scale following the loss of ZC3H4 or INTS1.  This illustrates that the effects of 1197 
ZC3H4 loss are both wider spread and larger than those associated with depletion of INTS1.  1198 
The list of targets in each case is provided in Supplementary File 6. 1199 
 1200 
Figure 4 – figure supplement 1  1201 
a) Pol II ChIP over ITPRID2 and MYC PROMPT regions.  Graphs plot Pol II occupancy as a 1202 
percentage of input at amplicons ~2, 4 and 8kb upstream of each gene.  N=4.  Error bars are 1203 
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SEM. * denotes p of <0.05.  The schematic illustrates the approximate location of each 1204 
primer pair. 1205 
b) qRT-PCR analysis of extended ITPRID2 and MYC PROMPTs (-8kb amplicons) in 1206 
chromatin-associated RNA isolated from ZC3H4-DHFR cells grown with or without (4hr) 1207 
TMP.  Y-axis displays fold change versus +TMP following normalisation to spliced actin 1208 
levels.  n=3.  Error bars are SEM.  * and ** denote p values of <0.05 and 0.01 respectively.  1209 
c) Western blot showing acute depletion of PNUTS (the nuclear targeting subunit of PP1 1210 
phosphatase), tagged with an auxin-inducible degron (PNUTS-AID).  Blot shows extracts 1211 
from unmodified HCT116 cells and PNUTS-AID cells which were treated or not with auxin 1212 
(3hr).  WDR82 is used as a loading control. 1213 
d) qRT-PCR of PROMPT and SE transcripts in PNUTS-AID cells treated or not with auxin (3 1214 
hr).  Graph shows fold change by comparison with non-auxin treated cells following 1215 
normalisation to spliced actin transcripts. N=3.  Error bars are SEM.  * and ** denote p 1216 
values of <0.05 and 0.01 respectively. 1217 
e) qRT-PCR analysis of PROMPT and SE transcripts in HCT116 cells treated with control 1218 
siRNAs or siRNAs against both SETD1A and B.  Quantitation shows fold change versus 1219 
cells transfected with control siRNAs following normalisation to spliced actin levels.  Note 1220 
that the PROMPT and SE targets that are increased following ZC3H4 loss show relatively 1221 
little change following depletion of SETD1A and B.  The success of the RNAi is indicated by 1222 
the strong reduction of SETD1A and B mRNAs. N=3.  Error bars show SEM.  ** denotes p 1223 
value of <0.01. 1224 
Figure 5 – figure supplement 1 1225 
a) XRNAX analysis of ZC3H4 RNA binding in cells.  Samples show input and those isolated 1226 
following UV treatment or not.  Bands representing each protein are labelled accordingly.  1227 
ZC3H4 is recovered in a UV-dependent manner indicating that it is directly bound to RNA in 1228 
cells.  The same is true of EXOSC10 that, as an exoribonuclease, acts as a positive control.  1229 
TCF4 is a DNA binding transcription factor and acts as a negative control. 1230 
b) ZC3H4 only marks transcribed super-enhancers. IGV track view of ZC3H4 and Pol II 1231 
occupancy at two different super-enhancers, DLAGAP1 present in both HEPG2 and 1232 
HCT116 (top tracks) and the MYC super-enhancer (bottom tracks) that is only present in 1233 
HCT116 cells. HEPG2 and HCT116 super-enhancer annotation is under each track as blue 1234 
bars and was obtained from dbSUPER.  Y-axis shows CPM. 1235 
Figure 6 – figure supplement 1 1236 
1 
 
a) qRT-PCR of ZC3H4-DHFR cells transfected with MS2-IRES-GFP before growth in the 1237 
presence or, to deplete ZC3H4, absence of TMP (4 hr).  Graph shows percentage of each 1238 
amplicon following TMP removal relative to that found in the presence of TMP following 1239 
normalisation to spliced actin transcripts.  N=3.  Error bars show SEM.  * denotes p<0.05. 1240 
b) qRT-PCR of HCT116 cells transfected with IRES-GFP and either a control beta-globin 1241 
plasmid (NTC) or ZC3H4-MS2.  The graph shows the percentage of GFP RNA versus 1242 
control following normalisation to spliced actin transcripts.  N=3.  Error bars show SEM.   1243 
SUPPLEMENTARY FILES 1244 
Supplementary File 1 1245 
Mass spectrometry data associated with the Pol II-miniTurbo experiment. 1246 
Supplementary File 2 1247 
Underpinning data for phylogenetic analyses. 1248 
Supplementary File 3 1249 
Log2 fold changes in read-through following CPSF30 or ZC3H4 depletion from HCT116 1250 
cells. 1251 
Supplementary File 4 1252 
List of mRNAs that are upregulated following ZC3H4 depletion (nuclear RNA-seq) or INTS1 1253 
depletion (chromatin-associated RNA-seq) in HCT116 cells. 1254 
Supplementary File 5 1255 
List of mRNAs that are upregulated following ZC3H4 depletion (4sU RNA-seq; (Austenaa et 1256 
al., 2021)) or INTS11 depletion (4sU TT-seq; (Lykke-Andersen et al., 2020)) in HeLa cells.  1257 
Genes in each set were manually checked for upregulation (TRUE) or possible artefacts – 1258 
primarily transcription from surrounding region into a gene that is consequently scored as 1259 
upregulated (FALSE). 1260 
Supplementary File 6 1261 
List of PROMPTs that are upregulated following ZC3H4 depletion (nuclear RNA-seq) or 1262 
INTS1 depletion (chromatin-associated RNA-seq) in HCT116 cells. 1263 
Supplementary File 7 1264 
Table of oligonucleotide and DNA sequences used in this study. 1265 
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Source data file 1 1266 
Values (average, SEM, p-value) of data underpinning graphs within the paper. 1267 
Source data file 2 1268 
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mRNA processing 7 6.62E-04
cellular macromolecule metabolic process 17 4.58E-03
RNA splicing 6 6.44E-03
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Figure 3-figure supplement 1
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Figure 6-figure supplement 1
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